MicroRNA Regulation of Ovarian Function
MicroRNA Regulation of Ovarian Function
批准号:
7898098
负责人:
LANE K. CHRISTENSON
金额:
$34.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2015-05-31
关键词:
AffectAgeAnimal ModelApoptosisApplications GrantsBindingCell Differentiation processCell physiologyCompetenceContraceptive AgentsContraceptive methodsDataData SetDefectDevelopmentElectrophoretic Mobility Shift AssayEnzymesEventFertilityFunctional disorderGene ChipsGene ExpressionGene Expression RegulationGene TargetingGenesGoalsHypertrophyInfertilityKnockout MiceKnowledgeLaboratoriesLinkLuteinizationLuteinizing HormoneMediatingMeiosisMicroRNAsMolecularMusOocytesOutcomeOvarianOvarian Granulosa CellOvarian TissueOvaryOvulationPathway interactionsPhysiologicalPhysiological ProcessesPhysiologyPlayPositioning AttributePost-Transcriptional RegulationPrincipal InvestigatorProcessProgesterone ReceptorsProteomicsPublicationsQuality of lifeRecruitment ActivityRegulationReproductive HealthResearchResearch PersonnelRoleShort luteal phaseSignal TransductionSomatic CellSyndromeSystemTechniquesTestingTherapeutic InterventionTimeTissuesTranscriptTranslationsWomanWorkanalytical methodbasecell growthchromatin immunoprecipitationcorpus luteumexperiencegranulosa cellhigh throughput analysisimprovedin vivoin vivo Modelinnovationmathematical modelpromoterprotein expressionpublic health relevancereceptorreproductivereproductive successresearch studyresponsetranscription factortreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Contraception and infertility are two major quality of life issues facing women of reproductive age. Ovulation of a fertilizable oocyte and formation of a functional corpus luteum are absolute requirements for reproductive success and are induced by the mid-cycle surge of luteinizing hormone (LH). Disrupted LH actions are a leading cause of infertility and a target of many contraceptive methods. Numerous studies have characterized the signaling cascades and transcriptional responses downstream of LH action; and dramatic progress in our understanding of how LH and its receptor are able to regulate such complicated physiological processes such as ovulation, resumption of meiosis and luteinization have resulted. However, significant questions still remain unsolved or unexplored, including the role post-transcriptional regulation of gene expression plays in mediating LH action. Our recent studies with Dicer1 deficient mice have implicated post-transcriptional and specifically microRNA mediated gene regulation as playing a key role in ovulation. We have also identified miR-21 as an LH- induced microRNA (miRNA) within granulosa cells of the periovulatory follicle, and demonstrated that it suppresses apoptosis and enhances granulosa cell hypertrophy by promoting global translation. Furthermore, our current in vivo studies demonstrate that loss of miR-21 decreases ovulation rate. Therefore, the central hypothesis of this proposal is that miR-21 plays critical roles in the LH-induced ovarian function. To test this central hypothesis, in Specific Aim1, we determine the function of miR-21 within periovulatory follicular granulosa cells and its role in ovulation, luteinization and oocyte competence. In Specific Aim 2, we identify the target transcripts and molecular pathways miR-21 regulates within periovulatory granulosa cells, while in Specific Aim 3 we determine which LH-induced transcription factors modulate miR-21 gene expression. The studies proposed in this grant application will define a subset of genes regulated by miR-21 mediated post-transcriptional gene regulation and will functionally link this miRNA with physiologic and developmental events critical to ovarian function. The long-term benefits of this research will enhance our understanding of the ovary, ultimately impacting the development of treatment strategies for infertility and new contraceptive methods for women.
PUBLIC HEALTH RELEVANCE: Infertility due to ovarian dysfunction such as polycystic ovarian syndrome, short luteal phase defects and compromised oocyte quality result from disrupted and abnormal cellular interactions occurring within the periovulatory follicle. Identifying the factors and their mechanisms of action that regulate ovarian function will provide targets for therapeutic intervention. The long-term benefits of this research will enhance our understanding of the ovary, ultimately impacting the development of treatment strategies that will improve the reproductive health of women.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Skeletal muscle extracellular vesicle signaling in Alzheimer's Disease prevention
-
批准号:9917535
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2020
-
负责人:LANE K. CHRISTENSON
-
依托单位:
Mitochondrial RNA defense pathways in the oocyte
-
批准号:10335216
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2018
-
负责人:LANE K. CHRISTENSON
-
依托单位:
Exosome / microvesicle regulation of oocyte developmental competence
-
批准号:8808377
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2014
-
负责人:LANE K. CHRISTENSON
-
依托单位:
Exosome / microvesicle regulation of oocyte developmental competence
-
批准号:8986806
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2014
-
负责人:LANE K. CHRISTENSON
-
依托单位:
KANSAS U COBRE: PREIMPLANTATION RELEASED PROTEINS EMBRYO QUALITY PREDICTORS
-
批准号:8167981
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2010
-
负责人:LANE K. CHRISTENSON
-
依托单位:
MicroRNA Regulation of Ovarian Function
-
批准号:8079548
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2010
-
负责人:LANE K. CHRISTENSON
-
依托单位:
MicroRNA Regulation of Ovarian Function
-
批准号:8277809
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2010
-
负责人:LANE K. CHRISTENSON
-
依托单位:
MicroRNA Regulation of Ovarian Function
-
批准号:8475357
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2010
-
负责人:LANE K. CHRISTENSON
-
依托单位:
MicroRNA Regulation of Ovarian Function
-
批准号:8676490
-
项目类别:
-
资助金额:$29.64万
-
财政年份:2010
-
负责人:LANE K. CHRISTENSON
-
依托单位:
KANSAS U COBRE: PREIMPLANTATION RELEASED PROTEINS EMBRYO QUALITY PREDICTORS
-
批准号:7959574
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2009
-
负责人:LANE K. CHRISTENSON
-
依托单位:
KANSAS U COBRE: PREIMPLANTATION RELEASED PROTEINS EMBRYO QUALITY PREDICTORS
-
批准号:7721036
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2008
-
负责人:LANE K. CHRISTENSON
-
依托单位:
KANSAS U COBRE: PREIMPLANTATION RELEASED PROTEINS EMBRYO QUALITY PREDICTORS
-
批准号:7610806
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2007
-
负责人:LANE K. CHRISTENSON
-
依托单位:
Post-transcriptional gene regulation in the ovary
-
批准号:7143215
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2006
-
负责人:LANE K. CHRISTENSON
-
依托单位:
Post-transcriptional gene regulation in the ovary
-
批准号:7282667
-
项目类别:
-
资助金额:$16.06万
-
财政年份:2006
-
负责人:LANE K. CHRISTENSON
-
依托单位:
In Vivo Trapping of Genes Involved in Ovulation
-
批准号:7079095
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2004
-
负责人:LANE K. CHRISTENSON
-
依托单位:
In Vivo Trapping of Genes Involved in Ovulation
-
批准号:6965074
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2004
-
负责人:LANE K. CHRISTENSON
-
依托单位:
VASCULAR DEVELOPMENT WITHIN THE PRIMATE CORPUS LUTEUM
-
批准号:2459782
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1997
-
负责人:LANE K. CHRISTENSON
-
依托单位:
VASCULAR DEVELOPMENT WITHIN THE PRIMATE CORPUS LUTEUM
-
批准号:2383468
-
项目类别:
-
资助金额:$2.22万
-
财政年份:1997
-
负责人:LANE K. CHRISTENSON
-
依托单位:
VASCULAR DEVELOPMENT WITHIN THE PRIMATE CORPUS LUTEUM
-
批准号:2196374
-
项目类别:
-
资助金额:$0.69万
-
财政年份:1996
-
负责人:LANE K. CHRISTENSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: